医薬品充填および仕上げアウトソーシングの世界市場レポート 2025年

医薬品充填および仕上げアウトソーシング市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.7％で、52億8,000万米ドルに成長します。予測期間の成長は、専門的なサービスへの需要、世界市場の拡大、コア・コンピタンスへの注力、新薬の急速な市場参入、製造能力の柔軟性、変動に対応するための柔軟な製造能力の必要性の予測などに起因すると考えられます。予測期間における主な動向としては、生物製剤アウトソーシングの増加、持続可能性への取り組み、アウトソーシング拠点の地理的拡大、効率化のための技術統合、開発・製造受託機関（CDMO）の増加などが挙げられます。

生物学的製剤に対する需要の増加は、今後の医薬品充填および仕上げアウトソーシング市場の成長を牽引すると予想されます。生物学的製剤は、生物学的製剤またはバイオシミラーと呼ばれることが多く、生物に由来する、または生物に由来する成分を含む医薬品のカテゴリーです。医薬品メーカーは、製造の充填・仕上げ段階をアウトソーシングすることで、製造受託機関（CMO）の専門知識とインフラを活用することができます。これにより、製薬会社は生物学的製剤の開発、研究、規模拡大に集中できる一方で、効率的でコスト効果の高い充填・仕上げ作業をCMOに頼ることができます。例えば、2023年9月、米国を拠点とするジェネリック医薬品・医薬化学品メーカーの業界団体であるAAM（Association for Accessible Medicines）は、2022年にはバイオシミラー医薬品による年間節約額が4,080億米ドルを超え、2021年と比較して350億米ドル増加したと報告しました。この動向は、ここ数年、貯蓄額の年間成長率が一貫して7～10％であることを示しています。したがって、生物学的製剤に対する需要の高まりが医薬品充填および仕上げアウトソーシング市場を押し上げると予想されます。

バイオ医薬品の研究開発（R&D）投資の増加は、医薬品充填および仕上げアウトソーシング市場の成長を大きく後押ししています。研究開発投資とは、バイオ医薬品の新製品を発見、開発し、最終的に市場に投入することを目的とした活動に割り当てられる財源を指します。イノベーションと医薬品開発を重視する製薬企業は、研究開発への資源配分を増やす可能性があります。充填・仕上げサービスのアウトソーシングにより、これらの企業は資源や投資を中核的な研究開発活動に振り向けることができます。例えば、スイスに本社を置くバイオ医薬品メーカー、ロシュ・ホールディングAGは2023年1月、2022年の研究開発費を2021年比で3.7%増額すると発表しました。その結果、バイオ医薬品企業による研究開発投資の増加が医薬品充填および仕上げアウトソーシング市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品充填および仕上げアウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医薬品充填および仕上げアウトソーシング市場：成長率分析
• 世界の医薬品充填および仕上げアウトソーシング市場の実績：規模と成長, 2019-2024
• 世界の医薬品充填および仕上げアウトソーシング市場の予測：規模と成長, 2024-2029, 2034F
• 世界の医薬品充填および仕上げアウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品充填および仕上げアウトソーシング市場：完成品状態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体
• 固体
• 半固形物
• 世界の医薬品充填および仕上げアウトソーシング市場：コンテンツ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物由来の有機物質
• 微生物から分離された有機物質
• 無機物質
• 世界の医薬品充填および仕上げアウトソーシング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品企業
• 製薬会社
• 世界の医薬品充填および仕上げアウトソーシング市場、液体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 溶液
• 懸濁液
• 世界の医薬品充填および仕上げアウトソーシング市場、固体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤
• カプセル
• 粉末
• 世界の医薬品充填および仕上げアウトソーシング市場、半固体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 軟膏
• クリーム
• ジェル

第7章 地域別・国別分析

• 世界の医薬品充填および仕上げアウトソーシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品充填および仕上げアウトソーシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品充填および仕上げアウトソーシング市場：競合情勢
• 医薬品充填および仕上げアウトソーシング市場：企業プロファイル
  • Groninger and Co. GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Wockhardt Limited. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• AbbVie Inc.
• Teva Pharmaceuticals Industries Ltd.
• Recipharm AB.
• Lonza Group AG
• Catalent Inc.
• Dr. Reddys Laboratories Ltd.
• West Pharmaceutical Services Inc.
• Sun Pharmaceutical Industries Ltd.
• Patheon N.V.
• Piramal Enterprises Ltd.
• Gerresheimer AG
• CordenPharma International
• Fujifilm Diosynth Biotechnologies
• Optima Packaging Group GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品充填および仕上げアウトソーシング市場2029：新たな機会を提供する国
• 医薬品充填および仕上げアウトソーシング市場2029：新たな機会を提供するセグメント
• 医薬品充填および仕上げアウトソーシング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical fill and finish outsourcing involves the practice of contracting with specialized pharmaceutical manufacturing companies to provide services related to pharmaceutical filling and sealing operations into end-use containers with the required sterility and accuracy. This outsourcing is employed by pharmaceutical and biopharmaceutical companies to leverage specialized expertise, avoid the high costs associated with acquiring automated equipment, meet stringent regulatory agency standards, enhance efficiency, and gain flexibility in terms of production capacity.

The primary types of pharmaceutical fill and finish outsourcing products are liquids, solids, and semi-solids. Liquids refer to pharmaceutical formulations that are pourable and consist of a combination of active drug or chemical components and inert components. These formulations may be processed from organic substances isolated from animal origin, organic substances isolated from microorganisms, and inorganic substances. Pharmaceutical and biopharmaceutical companies commonly utilize these outsourcing services for their production needs.

The pharmaceutical fill and finish outsourcing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical fill and finish outsourcing market statistics, including pharmaceutical fill and finish outsourcing industry global market size, regional shares, competitors with a pharmaceutical fill and finish outsourcing market share, detailed pharmaceutical fill and finish outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical fill and finish outsourcing industry. This pharmaceutical fill-and-finish outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical fill and finish outsourcing market size has grown strongly in recent years. It will grow from $3.53 billion in 2024 to $3.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to the emergence of contract development and manufacturing organizations (CDMOs, demand for specialized services, shift to outsourced models, market expansion strategies, and stringent regulatory requirements

The pharmaceutical fill and finish outsourcing market size is expected to see strong growth in the next few years. It will grow to $5.28 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to demand for specialized services, global market expansion, focus on core competencies, rapid market entry for new drugs, flexibility in manufacturing capacity, anticipated need for flexible manufacturing capacity to accommodate fluctuation. Major trends in the forecast period include increased biologics outsourcing, sustainability initiatives, geographic expansion of outsourcing hubs, technological integration for efficiency, rise in contract development and manufacturing organizations (CDMOs).

The increasing demand for biologic drugs is anticipated to drive the growth of the pharmaceutical fill and finish outsourcing market in the future. Biologic drugs, often referred to as biologics or biosimilars, are a category of pharmaceutical products derived from living organisms or containing components sourced from living organisms. By outsourcing the fill and finish phase of production, drug manufacturers can leverage the expertise and infrastructure of contract manufacturing organizations (CMOs). This enables pharmaceutical companies to concentrate on the development, research, and scaling of their biologic drugs while relying on CMOs for efficient and cost-effective fill and finish operations. For example, in September 2023, the Association for Accessible Medicines (AAM), a US-based trade association for manufacturers of generic prescription drugs and pharmaceutical chemicals, reported that in 2022, annual savings from biosimilar drugs exceeded $408 billion, reflecting a $35 billion increase compared to 2021. This trend indicates a consistent annual growth rate of 7-10 percent in savings in recent years. Therefore, the rising demand for biologic drugs is expected to boost the pharmaceutical fill and finish outsourcing market.

The rise in investments in biopharmaceutical research and development (R&D) is significantly fueling the growth of the pharmaceutical fill and finish outsourcing market. R&D investments refer to the financial resources allocated to activities aimed at discovering, developing, and eventually bringing new biopharmaceutical products to market. With a strong emphasis on innovation and drug development, pharmaceutical companies may increase their allocation of resources to research and development. Outsourcing fill and finish services allows these companies to redirect resources and investments toward core R&D activities. For instance, in January 2023, Roche Holding AG, a biopharmaceutical manufacturer based in Switzerland, announced a 3.7% increase in its R&D expenditure for 2022 compared to 2021. Consequently, the heightened investments in research and development by biopharmaceutical companies are driving the pharmaceutical fill and finish outsourcing market.

Product innovations represent a significant trend gaining traction in the pharmaceutical fill and finish outsourcing market. Companies within this sector are actively developing new and innovative products to maintain their competitive edge. For example, in January 2024, Stevanato Group, an Italy-based provider of drug containment and delivery solutions for the pharmaceutical and life sciences industries, introduced the EZ-fill Kit and a laboratory fill and finish service. The EZ-fill Kit is designed to streamline the filling process for small batches of injectable drugs, making it particularly beneficial during clinical trials and early commercial phases. This innovation helps pharmaceutical companies enhance small batch production, reduce costs, and accelerate time-to-market. Furthermore, the new non-GMP laboratory fill and finish service facilitates early evaluation of how the fill-and-finish process affects product performance. These innovations aim to improve efficiency and uphold high standards in drug development and production.

Leading companies in the pharmaceutical fill and finish outsourcing market are prioritizing the development of sustainable packaging materials and methods to reduce their carbon footprint and promote environmental conservation. Sustainable packaging involves creating and utilizing packaging that minimizes its environmental impact throughout its entire lifecycle. For instance, in November 2023, Amcor, an Australia-based pharmaceutical packaging company, launched next-generation HealthCare Recycle-Ready Medical Laminates. Amcor is producing all-film packaging that meets device application performance requirements while decreasing the overall carbon footprint of the final package and ensuring recyclability in the polyethylene stream. This solution features a polyethylene (PE) laminate that is a monomaterial suitable for various packaging formats, enabling it to replace non-recyclable lidding for 3D thermoformed packages with recyclable lidding for products such as drapes, protective materials, catheters, injection systems, and tubing systems.

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.8 billion. This strategic move allows AstraZeneca to strengthen its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat, an aldosterone synthase inhibitor (ASI), is designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.

Major companies operating in the pharmaceutical fill and finish outsourcing market include Groninger and Co. GmbH, Merck and Co.Inc., Abbott Laboratories, Wockhardt Limited., Boehringer Ingelheim International GmbH, Becton Dickinson and Company, AbbVie Inc., Teva Pharmaceuticals Industries Ltd., Recipharm AB., Lonza Group AG, Catalent Inc., Dr. Reddys Laboratories Ltd., West Pharmaceutical Services Inc., Sun Pharmaceutical Industries Ltd., Patheon N.V., Piramal Enterprises Ltd., Gerresheimer AG, CordenPharma International, Fujifilm Diosynth Biotechnologies, Optima Packaging Group GmbH, Jubilant HollisterStier LLC., Ajinomoto Bio-Pharma Services, Cytovance Biologics Inc., Grand River Aseptic Manufacturing, Baxter Pharmaceutical Solutions LLC., Halo Pharma Inc., MabPlex Inc., August Bioservices

North America was the largest region in the pharmaceutical fill and finish outsourcing market in 2024. The regions covered in the pharmaceutical fill and finish outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical fill and finish outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical fill and finish outsourcing market includes revenues earned by entities by providing outsourcing of aseptic or sterile filling and finishing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Fill and Finish Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical fill and finish outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical fill and finish outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical fill and finish outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By State Of Finished Products: Liquid, Solids, Semi Solids
• 2) By Content: Organic Substances Isolated From Animal Origin, Organic Substances Isolated From Microorganisms, Inorganic Substances
• 3) By End-Users: Biopharmaceutical Companies, Pharmaceutical Companies
• Subsegments:
• 1) By Liquid: Injectables Solutions Suspensions
• 2) By Solids: Tablets Capsules Powders
• 3) By Semi-Solids: Ointments Creams Gels
• Companies Mentioned: Groninger and Co. GmbH; Merck and Co.Inc.; Abbott Laboratories; Wockhardt Limited.; Boehringer Ingelheim International GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Fill and Finish Outsourcing Market Characteristics

3. Pharmaceutical Fill and Finish Outsourcing Market Trends And Strategies

4. Pharmaceutical Fill and Finish Outsourcing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pharmaceutical Fill and Finish Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Fill and Finish Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Fill and Finish Outsourcing Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Fill and Finish Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Fill and Finish Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Fill and Finish Outsourcing Total Addressable Market (TAM)

6. Pharmaceutical Fill and Finish Outsourcing Market Segmentation

• 6.1. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid
• Solids
• Semi Solids
• 6.2. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Organic Substances Isolated From Animal Origin
• Organic Substances Isolated From Microorganisms
• Inorganic Substances
• 6.3. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Pharmaceutical Companies
• 6.4. Global Pharmaceutical Fill and Finish Outsourcing Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectables
• Solutions
• Suspensions
• 6.5. Global Pharmaceutical Fill and Finish Outsourcing Market, Sub-Segmentation Of Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Powders
• 6.6. Global Pharmaceutical Fill and Finish Outsourcing Market, Sub-Segmentation Of Semi-Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ointments
• Creams
• Gels

7. Pharmaceutical Fill and Finish Outsourcing Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Fill and Finish Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Fill and Finish Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market

• 8.1. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Fill and Finish Outsourcing Market

• 9.1. China Pharmaceutical Fill and Finish Outsourcing Market Overview
• 9.2. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Fill and Finish Outsourcing Market

• 10.1. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Fill and Finish Outsourcing Market

• 11.1. Japan Pharmaceutical Fill and Finish Outsourcing Market Overview
• 11.2. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Fill and Finish Outsourcing Market

• 12.1. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Fill and Finish Outsourcing Market

• 13.1. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Fill and Finish Outsourcing Market

• 14.1. South Korea Pharmaceutical Fill and Finish Outsourcing Market Overview
• 14.2. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Fill and Finish Outsourcing Market

• 15.1. Western Europe Pharmaceutical Fill and Finish Outsourcing Market Overview
• 15.2. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Fill and Finish Outsourcing Market

• 16.1. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Fill and Finish Outsourcing Market

• 17.1. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Fill and Finish Outsourcing Market

• 18.1. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Fill and Finish Outsourcing Market

• 19.1. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Fill and Finish Outsourcing Market

• 20.1. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market

• 21.1. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market Overview
• 21.2. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Fill and Finish Outsourcing Market

• 22.1. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Fill and Finish Outsourcing Market

• 23.1. North America Pharmaceutical Fill and Finish Outsourcing Market Overview
• 23.2. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Fill and Finish Outsourcing Market

• 24.1. USA Pharmaceutical Fill and Finish Outsourcing Market Overview
• 24.2. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Fill and Finish Outsourcing Market

• 25.1. Canada Pharmaceutical Fill and Finish Outsourcing Market Overview
• 25.2. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Fill and Finish Outsourcing Market

• 26.1. South America Pharmaceutical Fill and Finish Outsourcing Market Overview
• 26.2. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Fill and Finish Outsourcing Market

• 27.1. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Fill and Finish Outsourcing Market

• 28.1. Middle East Pharmaceutical Fill and Finish Outsourcing Market Overview
• 28.2. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Fill and Finish Outsourcing Market

• 29.1. Africa Pharmaceutical Fill and Finish Outsourcing Market Overview
• 29.2. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Fill and Finish Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Fill and Finish Outsourcing Market Competitive Landscape
• 30.2. Pharmaceutical Fill and Finish Outsourcing Market Company Profiles
  • 30.2.1. Groninger and Co. GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Wockhardt Limited. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Fill and Finish Outsourcing Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. AbbVie Inc.
• 31.3. Teva Pharmaceuticals Industries Ltd.
• 31.4. Recipharm AB.
• 31.5. Lonza Group AG
• 31.6. Catalent Inc.
• 31.7. Dr. Reddys Laboratories Ltd.
• 31.8. West Pharmaceutical Services Inc.
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Patheon N.V.
• 31.11. Piramal Enterprises Ltd.
• 31.12. Gerresheimer AG
• 31.13. CordenPharma International
• 31.14. Fujifilm Diosynth Biotechnologies
• 31.15. Optima Packaging Group GmbH

32. Global Pharmaceutical Fill and Finish Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Fill and Finish Outsourcing Market

34. Recent Developments In The Pharmaceutical Fill and Finish Outsourcing Market

35. Pharmaceutical Fill and Finish Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Fill and Finish Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Fill and Finish Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Fill and Finish Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer